// App-Quantinova.ai

: SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

Researchers

Presenter

  • Rachna T. Shroff

Principal Investigators

  • Aaron James Scott

  • Mitesh J. Borad

  • Laura Williams Goff

  • Khalid Matin

  • Amit Mahipal

  • Aparna Kalyan

  • Milind M. Javle

  • Carol Aghajanian

  • Benjamin R. Tan

  • Puneet S. Cheema

  • Anuj K. Patel

  • Renuka V. Iyer

  • Robin Kate Kelley

  • Jaykumar Ranchodbhai Thumar

  • Anthony B. El-Khoueiry

  • E. Gabriela Chiorean

  • Howard S. Hochster

  • Philip Agop Philip

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Mayo Clinic, Rochester, MN

  • Mayo Clinic, Scottsdale, AZ

  • Henry Ford Cancer Institute, Detroit, MI

  • Washington University, St Louis, MO

  • Vanderbilt University Medical Center, Nashville, TN

  • Dana-Farber Cancer Institute, Boston, MA

  • USC Norris Comprehensive Cancer Center, Los Angeles, CA

  • Robert H. Lurie Cancer Center of Northwestern University, Chicago, IL

  • Saint John's Hospital, Saint Paul, MN

  • University of Washington and Fred Hutchinson Cancer Center, Seattle, WA

  • Massey Cancer Center, Richmond, VA

  • Fred Hutchiinson Cancer Research Center, and SWOG Statistics and Data Management Center, Seattle, WA

  • Yale Cancer Center, New Haven, CT

  • Roswell Park Cancer Institute, Buffalo, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

  • University of Arizona Cancer Center, Tucson, AZ

  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Paclitaxel

  • Cisplatin

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

Phase

  • III

Study Id's

  • NCT03768414

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved